{"id":"NCT02158572","sponsor":"Agile Therapeutics","briefTitle":"Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System","officialTitle":"A Single-arm, Open-label, Multicenter Phase 3 Study of the Contraceptive Efficacy, Safety and Tolerability of the AG200-15 Transdermal Contraceptive Delivery System (TCDS)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-08","primaryCompletion":"2016-11","completion":"2016-11","firstPosted":"2014-06-09","resultsPosted":"2017-09-25","lastUpdate":"2020-05-06"},"enrollment":2032,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Healthy"],"interventions":[{"type":"DRUG","name":"AG200-15","otherNames":["Transdermal contraceptive delivery system"]}],"arms":[{"label":"AG200-15","type":"EXPERIMENTAL"}],"summary":"Study of the efficacy of a contraceptive patch in 2100 healthy women for up to one year.","primaryOutcome":{"measure":"Contraception Efficacy of AG200-15 in Subjects â‰¤ 35 Years of Age Regardless of BMI, Intent-to-treat (ITT) Dataset.","timeFrame":"1 year","effectByArm":[{"arm":"AG200-15","deltaMin":5.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"FEMALE","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":7},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["33259782"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":40,"n":2031},"commonTop":["Nasopharyngitis","Upper respiratory infection","Nausea","Headache","Urinary tract infection"]}}